{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T21:34:27Z","timestamp":1779399267546,"version":"3.53.1"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T00:00:00Z","timestamp":1670284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Thymic epithelial tumors (TETs) are rare tumors that originated from thymic epithelial cells, with limited studies investigating their prognostic factors. This study aimed to investigate the prognostic factors of TETs and develop a new risk classifier to predict their overall survival (OS).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This retrospective study consisted of 1224 TETs patients registered in the Surveillance, Epidemiology, and End Results (SEER) database, and 75 patients from the First Affiliated Hospital of Xi\u2019an Jiaotong University. The univariate and multivariate Cox regression analyses were adopted to select the best prognostic variables. A nomogram was developed to predict the OS of these patients. The discriminative and calibrated abilities of the nomogram were assessed using the receiver operating characteristics curve (ROC) and calibration curve. Decision curve analysis (DCA), net reclassification index (NRI), and integrated discrimination improvement (IDI) were adopted to assess its net clinical benefit and reclassification ability.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The multivariate analysis revealed that age, sex, histologic type, TNM staging, tumor grade, surgery, radiation, and tumor size were independent prognostic factors of TETs, and a nomogram was developed to predict the OS of these patients based on these variables. The time-dependent ROC curves displayed that the nomogram yielded excellent performance in predicting the 12-, 36- and 60-month OS of these patients. Calibration curves presented satisfying consistencies between the actual and predicted OS. DCA illustrated that the nomogram will bring significant net clinical benefits to these patients compared to the classic TNM staging system. The estimated NRI and IDI showed that the nomogram could significantly increase the predictive ability of 12-, 36- and 60-month OS compared to the classic TNM staging system. Consistent findings were discovered in the internal and external validation\u00a0cohorts.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The constructed nomogram is a reliable risk classifier to achieve personalized survival probability prediction of TETs, and could bring significant net clinical benefits to these patients.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2022.1050364","type":"journal-article","created":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T07:00:01Z","timestamp":1670310001000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["A novel risk classifier for predicting the overall survival of patients with thymic epithelial tumors based on the eighth edition of the TNM staging system: A population-based study"],"prefix":"10.3389","volume":"13","author":[{"given":"Yimeng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujia","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuchu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiping","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2021.10.010","article-title":"The 2021 WHO classification of tumors of the thymus and mediastinum: What is new in thymic epithelial, germ cell, and mesenchymal tumors","volume":"17","author":"Marx","year":"2022","journal-title":"J Thorac Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.11099","article-title":"Malignant thymoma in the united states: demographic patterns in incidence and associations with subsequent malignancies","volume":"105","author":"Engels","year":"2003","journal-title":"Int J Cancer"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e3181f20c05","article-title":"Staging system of thymoma","volume":"5","author":"Masaoka","year":"2010","journal-title":"J Thorac Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0000000000000363","article-title":"Clinical characteristics and outcomes for patients with thymic carcinoma: evaluation of masaoka staging","volume":"9","author":"Litvak","year":"2014","journal-title":"J Thorac Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R","article-title":"Follow-up study of thymomas with special reference to their clinical stages","volume":"48","author":"Masaoka","year":"1981","journal-title":"Cancer."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1827.1994.tb02936.x","article-title":"A review of 79 thymomas: modification of staging system and reappraisal of conventional division into invasive and non-invasive thymoma","volume":"44","author":"Koga","year":"1994","journal-title":"Pathol Int"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0000000000000290","article-title":"The IASLC\/ITMIG thymic epithelial tumors staging project: proposal for an evidence-based stage classification system for the forthcoming (8th) edition of the TNM classification of malignant tumors","volume":"9","author":"Detterbeck","year":"2014","journal-title":"J Thorac Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.12.9791","article-title":"How to build and interpret a nomogram for cancer prognosis","volume":"26","author":"Iasonos","year":"2008","journal-title":"J Clin Oncol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"10732748211051228","DOI":"10.1177\/10732748211051228","article-title":"Construction and validation of a novel nomogram to predict the overall survival of patients with combined small cell lung cancer: A surveillance, epidemiology, and end results population-based study","volume":"28","author":"Jiang","year":"2021","journal-title":"Cancer Control"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2019.10.018","article-title":"A recurrence predictive model for thymic tumors and its implication for postoperative management: a Chinese alliance for research in thymomas database study","volume":"15","author":"Liu","year":"2020","journal-title":"J Thorac Oncol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1245\/s10434-021-10602-0","article-title":"Lymphatic node metastasis risk scoring system: A novel instrument for predicting lymph node metastasis after thymic epithelial tumor resection","volume":"29","author":"Cheng","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-020-07100-4","article-title":"Risk stratification of thymic epithelial tumors by using a nomogram combined with radiomic features and TNM staging","volume":"31","author":"Shen","year":"2021","journal-title":"Eur Radiol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jtcvs.2020.05.048","article-title":"Tumor size as a prognostic factor in limited-stage thymic epithelial tumors: A multicenter analysis","volume":"162","author":"Yun","year":"2021","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2016.03.24","article-title":"Clinicopathological analysis of 241 thymic epithelial tumors-experience in the shanghai chest hospital from 1997-2004","volume":"8","author":"Zhu","year":"2016","journal-title":"J Thorac Dis"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.18632\/aging.102897","article-title":"Clinical significance of age at diagnosis among patients with thymic epithelial tumors: a population-based study","volume":"12","author":"Liu","year":"2020","journal-title":"Aging (Albany NY)."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0000000000000303","article-title":"The IASLC\/ITMIG thymic epithelial tumors staging project: proposals for the T component for the forthcoming (8th) edition of the TNM classification of malignant tumors","volume":"9","author":"Nicholson","year":"2014","journal-title":"J Thorac Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2020.05.088","article-title":"Management and long-term outcomes of advanced stage thymoma in the united states","volume":"111","author":"Khorfan","year":"2021","journal-title":"Ann Thorac Surg"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezz001","article-title":"Tumour size determines both recurrence-free survival and disease-specific survival after surgical treatment for thymoma","volume":"56","author":"Okumura","year":"2019","journal-title":"Eur J Cardiothorac Surg"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.13464","article-title":"Surgical outcomes of 215 patients with thymic epithelial tumors: A single-center experience","volume":"11","author":"Tian","year":"2020","journal-title":"Thorac Cancer"},{"key":"B20","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s12957-017-1283-4","article-title":"Evaluation of the new TNM-staging system for thymic malignancies: impact on indication and survival","volume":"15","author":"Ried","year":"2017","journal-title":"World J Surg Oncol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/S0003-4975(03)00555-1","article-title":"Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan","volume":"76","author":"Kondo","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2014.09.124","article-title":"Thymic carcinoma outcomes and prognosis: results of an international analysis","volume":"149","author":"Ahmad","year":"2015","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezu277","article-title":"A meta-analysis of debulking surgery versus surgical biopsy for unresectable thymoma","volume":"47","author":"Hamaji","year":"2015","journal-title":"Eur J Cardiothorac Surg"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2022.10.016","article-title":"Surgical, radiation, and systemic treatments of patients with thymic epithelial tumours: A systematic review","author":"Falkson","year":"2022","journal-title":"J Thorac Oncol Off Publ Int Assoc For Study Lung Cancer"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2017.01.002","article-title":"The impact of postoperative radiotherapy for thymoma and thymic carcinoma","volume":"12","author":"Jackson","year":"2017","journal-title":"J Thorac Oncol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X06295361","article-title":"Decision curve analysis: a novel method for evaluating prediction models","volume":"26","author":"Vickers","year":"2006","journal-title":"Med Decis Making"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21388","article-title":"The eighth edition AJCC cancer staging manual: Continuing to build a bridge from a population-based to a more \"personalized\" approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA: Cancer J For Clin"},{"key":"B28","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.lungcan.2018.10.018","article-title":"Systemic treatments for thymoma and thymic carcinoma: A systematic review","volume":"126","author":"Berghmans","year":"2018","journal-title":"Lung Cancer (Amsterdam Netherlands)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2018.08.005","article-title":"Systemic therapy in advanced thymic epithelial tumors: Insights from the RYTHMIC prospective cohort","volume":"13","author":"Merveilleux du Vignaux","year":"2018","journal-title":"J Thorac Oncol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2022.01.021","article-title":"Thymic carcinomas-a concise multidisciplinary update on recent developments from the thymic carcinoma working group of the international thymic malignancy interest group","volume":"17","author":"Roden","year":"2022","journal-title":"J Thorac Oncol Off Publ Int Assoc For Study Lung Cancer"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2018.06.36","article-title":"Outcomes of patients undergoing surgery for thymic carcinoma: a single-center experience","volume":"10","author":"Nabe","year":"2018","journal-title":"J Thorac Dis"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.13181","article-title":"Optimal first-line treatment for advanced thymic carcinoma","volume":"10","author":"Yang","year":"2019","journal-title":"Thorac Cancer"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13205239","article-title":"Future perspective of chemotherapy and pharmacotherapy in thymic carcinoma","volume":"13","author":"Kitadai","year":"2021","journal-title":"Cancers."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv277","article-title":"Thymic epithelial tumours: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","author":"Girard","year":"2015","journal-title":"Ann Oncol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2017-0586","article-title":"Prognostic factors and efficacy of first-line chemotherapy in patients with advanced thymic carcinoma: A retrospective analysis of 286 patients from NEJ023 study","volume":"23","author":"Ko","year":"2018","journal-title":"Oncologist."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2015(12)03","article-title":"Chemotherapy and prognosis in advanced thymic carcinoma patients","volume":"70","author":"Song","year":"2015","journal-title":"Clinics (Sao Paulo)"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2019.12.111","article-title":"Surgery in masaoka stage IV thymic carcinoma: a propensity-matched study based on the SEER database","volume":"12","author":"Ye","year":"2020","journal-title":"J Thorac Dis"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2014.02.012","article-title":"The potency of curative-intent treatment for advanced thymic carcinoma","volume":"84","author":"Okuma","year":"2014","journal-title":"Lung Cancer (Amsterdam Netherlands)"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.32.9607","article-title":"Phase II study of carboplatin and paclitaxel in advanced thymoma and thymic carcinoma","volume":"29","author":"Lemma","year":"2011","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu541","article-title":"A multicenter phase II study of carboplatin and paclitaxel for advanced thymic carcinoma: WJOG4207L","volume":"26","author":"Hirai","year":"2015","journal-title":"Ann Oncol Off J Eur Soc For Med Oncol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2021.11.028","article-title":"Treatment strategies for thymic carcinoma in a real-life setting","volume":"162","author":"Petat","year":"2022","journal-title":"Insights RYTHMIC network Eur J Cancer (Oxford Engl 1990)"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyr089","article-title":"Combination chemotherapy with carboplatin and paclitaxel for advanced thymic cancer","volume":"41","author":"Furugen","year":"2011","journal-title":"Japanese J Clin Oncol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1050364\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T07:00:05Z","timestamp":1670310005000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1050364\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,6]]},"references-count":42,"alternative-id":["10.3389\/fendo.2022.1050364"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.1050364","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,6]]},"article-number":"1050364"}}